First Affiliated Hospital of Fujian Medical University
171
68
77
28
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.6%
1 terminated/withdrawn out of 171 trials
96.6%
+10.0% vs industry average
6%
11 trials in Phase 3/4
0%
0 of 28 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (171)
Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases
Role: lead
68Ga-FAPI PET/CT in Patients With Various Types of Cancer
Role: lead
A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure
Role: collaborator
Application of 68Ga-Pentixafor PET/CT in Primary Aldosteronism and Pre-postoperative of SAAE
Role: lead
China Research for Severe Spontaneous Intracerebral Hemorrhage（CRISIH）
Role: collaborator
Predictors of BCR After RARP for Localized Prostate Cancer: A Retrospective Analysis
Role: lead
68Ga-P16-093 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI
Role: lead
HAI or IV of Adebrelimab, Combined With Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular Carcinoma
Role: collaborator
Clinical Study of 177Lu-JH040182 in Patients With FAP-Positive Malignancies
Role: lead
China Antihypertensive Trial for Intracranial Aneurysm
Role: collaborator
Effect of Electroacupuncture on the Incidence of Postoperative Delirium in Elderly Patients Undergoing the Major Surgery
Role: collaborator
Real-World Study of Woven EndoBridge for Intracranial Aneurysm Treatment
Role: collaborator
Preventive Narrative Exposure Intervention for PTSD in ICU Patients After Cardiopulmonary Bypass Cardiac Surgery
Role: lead
Multicenter Registry Study of Patients With Intracranial Dural Arteriovenous Fistulas in China
Role: collaborator
Predicting BPH Surgery Outcomes Using a Preoperative Scoring System
Role: lead
A Multicenter, Prospective Clinical Trial With a Concurrent Control Evaluating Methotrexate Combined With Rituximab,Sintilimab and Pirtobrutinib vs. Investigator-Selected Standard of Care in Treatment-Naive PCNSL
Role: collaborator
FAPI and FDG PET/MRI in Diagnosis and Therapy Prediction of Bladder Cancer
Role: lead
PSMA PET/MRI-Guided Prostate Biopsy for PI-RADS ≤3 and Prior Negative Biopsy
Role: lead
Precise Profiling of Liver Disease Patients With DPMAS Therapy, Treating Optimal Patients and Achieving Hard Endpoint (PADSTONE Study)
Role: collaborator
CLIME-CJD: A Multimodal Study
Role: lead